Pharma has become much more comfortable partnering with influencers and celebrities on social media in recent years — whether it’s Lady Gaga touting Pfizer’s Nurtec, Jamie-Lynn Sigler posting about ...
The US Food and Drug Administration (FDA) will, by default, require only one clinical trial to demonstrate that a product meets its regulatory requirements for safety and efficacy in most cases, ...
BALTIMORE – Without guidance from the US Food and Drug Administration (FDA), experts said that companies must develop their own best practices for using artificial intelligence (AI) for pharmaceutical ...
Experts urge Kerala to adopt a cost-effective procurement policy for Spinal Muscular Atrophy drugs, prioritizing approved generics over high-priced patents.
That perception is outdated, however, as regulatory strategy now represents a source of competitive advantage rather than mere compliance. Regulatory expertise can de‑risk programs, accelerate ...
Brings more than 25 years of global drug development, regulatory and strategic leadership experience successfully guiding innovative therapies from clinical development through regulatory approval and ...
FDA’s focus on playing a direct role in lowering drug prices may provide opportunities for some pharmaceutical companies to seek a regulatory advantage. But it also places enormous pressure on ...
Most pharma brands by now are either already working with influencers or considering doing so in the future, given the opportunity to grab a wider audience on platforms like Instagram and TikTok.
Medindia on MSN
Why Has the Centre Banned 16 Fixed-Dose Combination Drugs?
India, June 22 -- The center has banned 16 Fixed-Dose Combination (FDC) drugs across India after an expert review found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results